Organization: MDS Capital Corp

MDS sells public retail VC funds to Impax Capital

MDS Capital Corp has flipped its ownership of Canadian Venture Capital Management Corp (CVCMC) and Medical Discoveries Management Corp (MDMC to Impax Capital Corp, just three months after acquiring 100% control (R$, September 2/05). The sale of its public retail VC funds is the first major move in a restructuring announced by new CEO Peter…

MDS acquires Stilco shares in VC management firms

MDS Capital Corp has acquired the shares of the Canadian Venture Capital Management Corp (CVCMC) from Stilco Investments Ltd and to become its sole shareholder and operator. MDS also acquired from Stilco all the shares of Medical Discovery Management Corp (MDMC), manager of the Canadian Medical Discoveries Funds I and II. Stilco is controlled by…

Two labour-sponsored funds to get new owners

Fullarton Capital Corp, managers of Capital Alliance Ventures Inc (CAVI). and the Canadian Science and Technology Growth Fund Inc (CSTGF), is negotiating to sell its company to GrowthWorks WV Management Ltd. The merger will give GrowthWorks combined assets of about $800 million, making it the third largest labour sponsored fund manager behind Fonds de solidarité…

MDS investment spurs Canadian joint venture

MDS Capital Corp is the lead investor in a $9.2-million financing of ViOptix Inc, a Fremont CA-based developer of optical diffusion imaging and spectroscopy technology for use in plastic, reconstructive and vascular surgery. The financing also involves the creation of a private joint venture company based in Toronto. ViOptix Canada also receives funding from the…

MDS and Acqua launch life sciences advisory firm

Toronto’s MDS Capital Corp has teamed with Acqua Wellington Asset Management, New York to form Vengate Capital Partners, a joint venture offering strategic and financial advisory services to emerging life sciences firms. The company will focus on providing financing strategies to help bridge the gap between traditional rounds of financing and assist firms in accelerating…

Venture fund to be extended by two years

Market conditions have prompted the Health Care & Biotechnology Venture Fund to be extended two years until February 28/04. The closed-end investment trust managed by MDS Capital Corp will divest all of its assets by that date at the latest. The fund has already paid in excess of its paid-in capital to unit holders and…